All Pharma News
price-trendAsk Us
With MDMA debate spreading, Lykos CEO tries to dispel concerns

With MDMA debate spreading, Lykos CEO tries to dispel concerns
Annalee Armstrong FIERCE BIOTECH
13 Jun 2024
Share Share
After ‘sobering’ FDA panel, psychedelics supporters wonder what’s next

After ‘sobering’ FDA panel, psychedelics supporters wonder what’s next
Jacob Bell BIOPHARMADIVE
07 Jun 2024
Share Share
US FDA panel votes against first MDMA-based PTSD treatment

US FDA panel votes against first MDMA-based PTSD treatment
REUTERS
05 Jun 2024
Share Share
Lykos: Updates On FDA Panel For MDMA-Assisted PTSD Therapy

Lykos: Updates On FDA Panel For MDMA-Assisted PTSD Therapy
PR NEWSWIRE
04 Jun 2024
Share Share
Ahead Of MDMA Approval, FDA Raises Trial Design, Safety Concerns

Ahead Of MDMA Approval, FDA Raises Trial Design, Safety Concerns
ENDPTS
01 Jun 2024
Share Share
As adcomm looms, ICER raises questions over Lykos’ MDMA studies

As adcomm looms, ICER raises questions over Lykos’ MDMA studies
ENDPTS
15 May 2024
Share Share
FDA advisers to weigh first psychedelic therapy in early June

FDA advisers to weigh first psychedelic therapy in early June
Max Bayer FIERCE BIOTECH
07 May 2024
Share Share
US FDA panel to discuss first psychedelic-assisted PTSD treatment next month

US FDA panel to discuss first psychedelic-assisted PTSD treatment next month
REUTERS
07 May 2024
Share Share
Psychedelic-assisted drug developer MAPS PBC nabs $100M

Psychedelic-assisted drug developer MAPS PBC nabs $100M
Kyle LaHucik ENDPTS
05 Jan 2024
Share Share